A Study of Replagal in Treatment-naïve Adults With Fabry Disease
NCT04840667
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class
Stopped
Study closed due to enrolment challenges, not for any safety issues
Conditions
Fabry Disease
Interventions
DRUG:
REPLAGAL
Sponsor
Shire